Pregnancy And Psychiatric Medication: Navigating Safe Options For Mother And Child

what psychiatric meds safe to take during pregnancy

Psychiatric medication during pregnancy is a complex issue that requires careful consideration of the risks and benefits involved. Traditionally, psychiatric medications were avoided during pregnancy due to concerns about potential harm to the fetus. However, recent evidence suggests that many commonly prescribed psychiatric medications are relatively safe and that discontinuing medication can lead to adverse effects on the mother's mental health. The decision to continue or discontinue medication should be made on a case-by-case basis, weighing the risks of fetal exposure to the medication against the risks associated with untreated psychiatric illness in the mother.

Characteristics Values
Psychiatric medication safe to take during pregnancy Tricyclic antidepressants, fluoxetine (Prozac), lamotrigine (Lamictal), alprazolam (Xanax), clonazepam (Klonopin), diazepam (Valium), citalopram (Celexa), sertraline (Zoloft), bupropion (Wellbutrin), trazodone (Desyrel), venlafaxine (Effexor), nefazodone (Serzone), mirtazapine (Remeron), aripiprazole (Abilify), haloperidol (Haldol), perphenazine (Trilafon), trifluoperazine (Stelazine), olanzapine (Zyprexa), risperidone (Risperdal), clozapine (Clozaril), quetiapine (Seroquel)
Psychiatric medication to be avoided during pregnancy Paroxetine (Paxil), lithium, valproic acid (Depakene), carbamazepine (Tegretol), chlorpromazine (Thorazine), thioridazine (Mellaril), thiothixene (Navane), ziprasidone (Geodon), fluphenazine (Prolixin), perphenazine (Trilafon), buspirone (BuSpar), zolpidem (Ambien), zalepion (Sonata)

shunchild

Antidepressants and pregnancy

Pregnancy has traditionally been viewed as a time of emotional well-being, but recent studies suggest that up to 20% of women suffer from mood or anxiety disorders during pregnancy. Deciding whether to continue or stop using antidepressants during pregnancy is one of the hardest decisions a woman must make.

Weighing the Risks

There are some risks to taking antidepressants during pregnancy. These include:

  • Possible birth defects, such as heart defects, spina bifida, or cleft lip
  • Increased risk of miscarriage and premature birth
  • Slightly increased risk of blood loss after childbirth
  • Withdrawal symptoms in the newborn baby, such as jitteriness, poor muscle tone, difficulty breathing, and low blood sugar

However, it's important to keep in mind that the risk of these complications is generally very low. Research has shown that most antidepressants, especially selective serotonin reuptake inhibitors (SSRIs) and older medications, are generally considered safe during pregnancy.

Weighing the Benefits

There are also benefits to taking antidepressants during pregnancy. Untreated depression can have harmful effects on both the mother and the baby. Women who are depressed are less likely to take proper care of themselves and may engage in risky behaviours such as drinking alcohol, smoking, or taking drugs during pregnancy. This can lead to serious health problems for the baby, including miscarriage, preterm birth, and low birth weight.

Additionally, untreated depression can take a toll on family dynamics, affecting the mother's relationship with her spouse and other children. If depression is preventing a mother from caring for her family, staying on antidepressants during pregnancy may be the best option.

Making the Decision

When deciding whether to continue or stop taking antidepressants during pregnancy, it's important to consider both the mother's health and the health of the unborn child. It's crucial to discuss the decision with a doctor, who can help weigh the pros and cons of continuing or stopping the medication.

If a woman has mild depression and has been symptom-free for at least six months, she may be able to stop using antidepressants under a doctor's supervision before or during pregnancy. Psychotherapy and lifestyle measures such as yoga, meditation, and stress reduction may be sufficient to manage her depression.

However, if a woman has a history of severe or recurrent depression, other mental illnesses, or suicidal thoughts, it is generally recommended to continue taking antidepressants during pregnancy.

Antidepressants and Breastfeeding

If a woman is breastfeeding, antidepressants can be passed to the baby through breast milk, and it is possible that the levels could become high enough to cause side effects in the baby. In general, tricyclic antidepressants should be avoided during breastfeeding, except for nortriptyline (Pamelor) and desipramine (Norpramin), which are considered safe.

shunchild

Mood stabilizers and pregnancy

Mood stabilizers are drugs used to treat bipolar disorder, a brain disorder that can cause abnormal changes in a person's mood, cognitive function, and quality of life. The use of mood stabilizers in pregnant and breastfeeding women must be carefully considered for impacts on fetal development as well as risks to the mother.

Lithium

Lithium is a mood stabilizer that has been associated with a high number of reported adverse effects in the general population. It is also associated with a high risk of teratogenicity, especially during the first trimester of pregnancy. However, newer research finds that there is some increase in risk of heart defects, but it is smaller than previously believed. As a result, lithium now falls into a middle-risk category. Women who choose to continue lithium during pregnancy should have more frequent lab tests, since the physical changes during pregnancy and delivery can cause big changes in lithium levels.

Valproate

Valproate is considered harmful to both the mother and fetus during pregnancy, but may be a compatible option for breastfeeding. It is a well-studied teratogen that can cause detrimental effects to maternal and fetal well-being. It has been associated with a high risk of serious birth defects, including spina bifida and other neural tube defects. It has also been linked to an increased risk of autistic spectrum disorders and infant neurodevelopmental delay.

Carbamazepine

Carbamazepine is found to cause serious malformations with the developing fetus as well as metabolic effects with the mother. However, it is found to cause little effect in breastfed infants as it does not readily pass through breast milk. It has been associated with a lower risk of causing spina bifida when compared to valproate but a greater risk of causing cleft palate when compared to lamotrigine.

Lamotrigine

Lamotrigine has been recognized as the overall safest mood stabilizer when both maternal and fetal complications are reviewed. It has been proven to pass through breast milk, negating its use during lactation. There is no clear risk of birth defects, but we don't know enough to say that there is no risk.

shunchild

Antipsychotic agents and pregnancy

Antipsychotic agents are used to treat several types of mental illness, including schizophrenia, bipolar disorder, psychosis, and depression. They are also used off-label for sleep and anxiety. Antipsychotics are typically introduced when non-pharmacological approaches fail to produce desired effects or when the risks outweigh the benefits of continuing without treatment or exposing the fetus to medication.

Antipsychotics can cross the placenta and enter breast milk. The decision to take antipsychotics during pregnancy and breastfeeding must consider the risks and benefits to both mother and child. Untreated maternal mental illness may lead to poor prenatal care, inadequate nutrition, and increased alcohol and tobacco use. It may also negatively impact the infant's development and well-being.

The risks associated with antipsychotic use during pregnancy include congenital abnormalities, preterm birth, and metabolic disturbances, which could lead to abnormal fetal growth. The specific fetal serum levels are unknown, but they may be higher than maternal levels.

First-generation antipsychotics (FGAs) have been available since the 1950s, while second-generation antipsychotics (SGAs) have been available since the 1990s. FGAs have not been associated with congenital malformations. However, a small but statistically significant increased risk for nonspecific teratogenic effects has been linked to first-trimester exposure to low-potency FGAs. On the other hand, SGAs may be associated with gestational diabetes and an increased risk of diabetes in adult patients.

While there is limited evidence of the teratogenic effects of antipsychotics, the risks of untreated or inadequately treated mental illness must also be considered. The decision to take antipsychotics during pregnancy should be made before conception, and the use of a single medication at a higher dosage is preferred over multiple medications.

shunchild

Anti-anxiety medications and pregnancy

Pregnancy is a time of great emotional change for women, with hormonal shifts, increased stress, and anxiety. It is common for doctors to advise women with mood disorders to stop taking antidepressants during pregnancy, but this can leave mothers-to-be conflicted about giving up the medications that help keep them healthy.

The Risks of Untreated Anxiety

Anxiety during pregnancy can negatively affect both the mother and the fetus. Research suggests that untreated anxiety may increase the risk of preterm birth, low birth weight, earlier gestational age, and a smaller head circumference (which is related to brain size). It can also cause lower infant birth weight, lower gestational age, altered Apgar scores, and impairment of fetal hemodynamics and fetal movement.

Anti-anxiety Medications and Their Risks

All anti-anxiety medications cross the placenta and enter the amniotic fluid. The potential risks to the fetus must be weighed against the risks of relapse if treatment is discontinued.

Selective Serotonin Reuptake Inhibitors (SSRIs)

SSRIs are commonly prescribed for anxiety during pregnancy. They are considered the "safest" anti-anxiety medications, with a low risk of harm to the fetus. However, SSRIs may be associated with transient neonatal symptoms such as jitteriness, tremors, crying, and trouble feeding, which usually resolve within a few days.

Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)

SNRIs are less commonly prescribed than SSRIs but are still considered safe to take during pregnancy in most cases.

Benzodiazepines

The use of benzodiazepines during pregnancy, especially in the first trimester, is controversial. While older studies showed a link between their use and an increased risk of cleft lip and palate, more recent studies have not found this association when the medications are used alone. However, there may be an increased risk when combined with antidepressants. Benzodiazepines should be avoided in high doses as they can lead to sedation and respiratory distress in the newborn.

Non-Pharmacological Treatments

Non-pharmacological treatments such as cognitive-behavioral therapy (CBT) are recommended as a first-line treatment for anxiety during pregnancy. CBT focuses on challenging maladaptive thoughts, emotions, and actions, and it uses anxiety management strategies such as diaphragmatic breathing. Other techniques that may help manage anxiety during pregnancy include regular physical activity, adequate sleep, mindfulness, journaling, and relaxation techniques such as yoga, massage, meditation, and acupuncture.

Tapering Off Medication

If a pregnant individual decides to stop taking their anti-anxiety medication after consulting their healthcare provider, the medication will be slowly tapered off to avoid side effects, which may include nausea, irritability, and fatigue.

The decision to continue or discontinue anti-anxiety medication during pregnancy should be made in consultation with a healthcare professional, considering the risks and benefits for both the mother and the fetus.

shunchild

Pregnancy and mental illness

Pregnancy is often thought of as a time of positive feelings, but it can also be demanding. It is a time of hormonal and physiological changes, and it can be stressful. It is a common myth that hormones released during pregnancy protect women from psychiatric disorders, but studies show that up to 20% of pregnant people experience anxiety or depression.

Treatment

It is important to treat mental health issues during pregnancy. Untreated mental illness can cause significant morbidity for both the mother and child. It can also lead to poor nutrition, smoking, drinking, and the use of other substances that can harm the unborn baby.

Treatment for mental health issues during pregnancy may include prescription medicine and talk therapy. It is important to talk to a doctor before starting or stopping any medication during pregnancy, as stopping medication can lead to withdrawal or a relapse of symptoms.

Medication

The U.S. Food and Drug Administration (FDA) has not approved any psychiatric medications for use during pregnancy, but this does not necessarily mean they are unsafe. Some medications may be safe to take under the care of a doctor.

Antidepressants, mood stabilizers, and antipsychotic medications may be safe to take during pregnancy, but it is important to discuss the risks and benefits with a doctor.

Support

Having a support network of family and friends can be helpful for people with mental health issues during pregnancy. It can be helpful to tell people you trust about your condition so that they can help you find ways to relax and reduce stress.

There are also professional support services available for pregnant people with mental health issues, such as perinatal mental health services and community mental health teams.

Frequently asked questions

All medications readily cross the placenta, and no psychotropic drug has been approved by the FDA for use during pregnancy. The risks associated with prenatal exposure include the risk of teratogenesis, neonatal toxicity, and long-term neurobehavioral effects.

Teratogenesis refers to the interference of the in utero development process, resulting in organ malformation or dysfunction. The timing of exposure to chemical agents during development affects the risk for malformations. The critical period for structural teratogenesis is from two to eight weeks post-fertilization, during which the development of major organ systems occurs.

Neonatal toxicity or perinatal syndromes refer to a range of physical and behavioural symptoms observed in newborns that can be attributed to drug exposure at or near the time of delivery. These symptoms may include somnolence, hypotonia, poor feeding, and irritability.

As neuronal migration and differentiation occur throughout pregnancy and early life, the central nervous system remains vulnerable to toxic agents. Exposures to teratogens early in pregnancy may result in clear abnormalities, while exposures after neural tube closure may produce more subtle changes in behaviour and functioning.

While knowledge about the risks of prenatal exposure to psychotropic medications is incomplete, data accumulated over the years suggest that some medications may be used safely. The tricyclic antidepressants and fluoxetine (Prozac) appear to be free of teratogenic effects, and emerging data support the safety of other selective serotonin reuptake inhibitors (SSRIs). However, paroxetine (Paxil) should be avoided due to its association with cardiac defects. Other antidepressants such as bupropion (Wellbutrin) and venlafaxine (Effexor) have not shown an increased risk of malformations. For bipolar disorder, lamotrigine (Lamictal) is an option for maintenance therapy as it has not been associated with major fetal anomalies.

Written by
Reviewed by
Share this post
Print
Did this article help you?

Leave a comment